Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BMY - OncoSec: Undervalued And Continuing To Make Progress

BMY - OncoSec: Undervalued And Continuing To Make Progress

Bristol-Myers Squibb Company
  • OncoSec has had very promising results in metastatic melanoma.
  • It has also expanded its program in triple-negative breast cancer to now treat first-line patients.
  • I review data from the melanoma program to help explain its significance.
  • The stock is up on the news, but I believe that these developments still haven't been fully reflected in the ONCS stock price.

For further details see:

OncoSec: Undervalued And Continuing To Make Progress
Stock Information
Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Website: bms.com
Menu
BMY BMY Quote BMY Short BMY News BMY Articles BMY Message Board
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...